A Study of LY2216684 and Warfarin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY2216684 and Theophylline in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Trial in Patients With Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas
- Status
- COMPLETED
- Phase
- PHASE1
A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Japanese Rheumatoid Arthritis Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
A Study for Japanese Participants With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
- Status
- COMPLETED
- Phase
- PHASE1
LY2189265 and Atorvastatin Interaction Study
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE1
A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2608204 in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3009104(Baricitinib) for Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2157299 in Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2